Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter

[ad_1] Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.…